Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus.

Rheumatology (Oxford, England)

Volumn 50, Issue 11, 2011, Pages 2071-2079

  Kiani, Adnan N ^a   Post, Wendy S ^b   Magder, Laurence S ^b   Petri, Michelle ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CALCIUM; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; PYRROLE DERIVATIVE;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DISEASE COURSE; FEMALE; HUMAN; MALE; METABOLISM; PATHOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

ADULT; ANTICHOLESTEREMIC AGENTS; ATHEROSCLEROSIS; CALCIUM; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; COMORBIDITY; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; HEPTANOIC ACIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MARYLAND; PYRROLES;

EID: 84855183264     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker285     Document Type: Article

References (0)